Seiji Sakata
Target (United States)(US)Cancer Institute (WIA)(IN)Open Targets(GB)Japanese Foundation For Cancer Research(JP)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Viral-associated cancers and disorders, Cancer Immunotherapy and Biomarkers, Chronic Lymphocytic Leukemia Research, T-cell and Retrovirus Studies
Most-Cited Works
- → RET, ROS1 and ALK fusions in lung cancer(2012)1,321 cited
- → Somatic RHOA mutation in angioimmunoblastic T cell lymphoma(2014)635 cited
- → Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers(2016)630 cited
- → KLC1-ALK: A Novel Fusion in Lung Cancer Identified Using a Formalin-Fixed Paraffin-Embedded Tissue Only(2012)261 cited
- → Secreted PD-L1 variants mediate resistance to PD-L1 blockade therapy in non–small cell lung cancer(2019)240 cited
- → Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas(2019)144 cited